Ovaa H - Search Results

1

Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.

Berkers CR, de Jong A, Schuurman KG, Linnemann C, Geenevasen JA, Schumacher TN, Rodenko B, Ovaa H. Berkers CR, et al. Among authors: ovaa h. J Immunol. 2015 Nov 1;195(9):4075-84. doi: 10.4049/jimmunol.1402454. Epub 2015 Sep 23. J Immunol. 2015. PMID: 26401000 Free PMC article.

2

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.

Berkers CR, Verdoes M, Lichtman E, Fiebiger E, Kessler BM, Anderson KC, Ploegh HL, Ovaa H, Galardy PJ. Berkers CR, et al. Among authors: ovaa h. Nat Methods. 2005 May;2(5):357-62. doi: 10.1038/nmeth759. Epub 2005 Apr 21. Nat Methods. 2005. PMID: 15846363

3

Immunotherapeutic potential for ceramide-based activators of iNKT cells.

Berkers CR, Ovaa H. Berkers CR, et al. Among authors: ovaa h. Trends Pharmacol Sci. 2005 May;26(5):252-7. doi: 10.1016/j.tips.2005.03.005. Trends Pharmacol Sci. 2005. PMID: 15860372 Review.

4

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

Chauhan D, Catley L, Li G, Podar K, Hideshima T, Velankar M, Mitsiades C, Mitsiades N, Yasui H, Letai A, Ovaa H, Berkers C, Nicholson B, Chao TH, Neuteboom ST, Richardson P, Palladino MA, Anderson KC. Chauhan D, et al. Among authors: ovaa h. Cancer Cell. 2005 Nov;8(5):407-19. doi: 10.1016/j.ccr.2005.10.013. Cancer Cell. 2005. PMID: 16286248 Free article.

5

Design and use of conditional MHC class I ligands.

Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JB, Ovaa H, Schumacher TN. Toebes M, et al. Among authors: ovaa h. Nat Med. 2006 Feb;12(2):246-51. doi: 10.1038/nm1360. Epub 2006 Feb 5. Nat Med. 2006. PMID: 16462803

6

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

Groll M, Berkers CR, Ploegh HL, Ovaa H. Groll M, et al. Among authors: ovaa h. Structure. 2006 Mar;14(3):451-6. doi: 10.1016/j.str.2005.11.019. Structure. 2006. PMID: 16531229 Free article.

7

Chemical proteomics profiling of proteasome activity.

Verdoes M, Berkers CR, Florea BI, van Swieten PF, Overkleeft HS, Ovaa H. Verdoes M, et al. Among authors: ovaa h. Methods Mol Biol. 2006;328:51-69. doi: 10.1385/1-59745-026-X:51. Methods Mol Biol. 2006. PMID: 16785641

8

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.

Kraus M, Rückrich T, Reich M, Gogel J, Beck A, Kammer W, Berkers CR, Burg D, Overkleeft H, Ovaa H, Driessen C. Kraus M, et al. Among authors: ovaa h. Leukemia. 2007 Jan;21(1):84-92. doi: 10.1038/sj.leu.2404414. Epub 2006 Oct 5. Leukemia. 2007. PMID: 17024115

9

A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.

Verdoes M, Florea BI, Menendez-Benito V, Maynard CJ, Witte MD, van der Linden WA, van den Nieuwendijk AM, Hofmann T, Berkers CR, van Leeuwen FW, Groothuis TA, Leeuwenburgh MA, Ovaa H, Neefjes JJ, Filippov DV, van der Marel GA, Dantuma NP, Overkleeft HS. Verdoes M, et al. Among authors: ovaa h. Chem Biol. 2006 Nov;13(11):1217-26. doi: 10.1016/j.chembiol.2006.09.013. Chem Biol. 2006. PMID: 17114003

10

Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Rodenko B, Toebes M, Hadrup SR, van Esch WJ, Molenaar AM, Schumacher TN, Ovaa H. Rodenko B, et al. Among authors: ovaa h. Nat Protoc. 2006;1(3):1120-32. doi: 10.1038/nprot.2006.121. Nat Protoc. 2006. PMID: 17406393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters